Bioimpedance Analyzers Market

Bioimpedance Analyzers Market by Type (Single-frequency, Multiple-frequency, Dual-frequency) Modality (Wired, Wireless) Application (Segmental Body Measurement, Whole Body Measurement) End User (Hospitals, Home Users) - Analysis & Global Forecasts to 2026

Report Code: MD 7973 Sep, 2021, by marketsandmarkets.com

[192 Pages Report] The global bioimpedance analyzers market size is projected to reach USD 767 million by 2026 from USD 429 million in 2021, at a CAGR of 10.2% during the forecast period. Growth of the market is driven mainly by the growing prevalence of lifestyle diseases such as obesity, increasing awareness on healthy lifestyles, and the growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers.

Bioimpedance Analyzers Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID -19 IMPACT ON THE BIOIMPEDANCE ANALYZERS MARKET

The COVID-19 pandemic is expected to have a positive impact on the bioimpedance analyzers market. The WHO has confirmed that more than 95% of the deaths in Europe occurred in patients older than 60 years, and more than 50% of all global fatalities involved people aged 80 years or older. WHO studies further reported that eight in ten deaths occurred in individuals with at least one comorbidity, such as CVD, hypertension, and diabetes.

COVID-19 causes a breakdown of muscle mass and a decreased appetite. This leads to malnutrition and significant loss of muscle mass. This is an important consideration for obese people, as they already have very low muscle mass. The European Society for Clinical Nutrition and Metabolism (ESPEN) gives practical guidance for the nutritional management of COVID-19 patients, emphasizing the importance of muscle mass. Thus, assessing body composition and muscle mass during hospitalization and also afterward is extremely important to protect patients as well as manage and monitor their improvement.

Global Bioimpedance Analyzers Market Dynamics

DRIVER: Increasing prevalence of lifestyle diseases

Unhealthy lifestyles, such as sedentary work environments, consumption of junk food, and increased mobility automation have increased the prevalence of various lifestyle diseases, such as obesity, high blood pressure, and diabetes.

According to the CDC, the global prevalence of obesity increased to 42.4% in 2019 from 30.5% in 2000. Obesity is now termed a worldwide epidemic; approximately 57.8% of all adults are expected to be classified as obese by 2030 (Source: WHO, 2020). In addition to developed countries, obesity is now an epidemic in low- and middle-income countries as well. As of 2019, in Africa, the prevalence of childhood obesity has increased by approximately 24% since 2000. Bioimpedance analyzers offer an accurate measurement of the amount of fat, muscle, and bone in the human body. This will fueling the growth of the bioimpedance analyzers market.

OPPORTUNITY: Emerging market across the Asia Pacific and Latin America

Emerging economies such as India, China, and Brazil are expected to witness high growth in the bioimpedance analyzers market. This can be attributed to the increasing prevalence of lifestyle diseases, growing awareness about health and obesity, and infrastructural improvements in these countries. China is a prominent market in this regard, given its recent infrastructural improvements, rapid economic growth, rising domestic demand, and public-private initiatives to support healthcare research. China’s State Council approved the 2016–2020 National Fitness Plan, which has motivated all national fitness levels and increased sports participation.

CHALLENGE: Inconsistency in the accuracy of different bioimpedance analyzers

Although the technology is improving, it is difficult to obtain accurate body fat measurements from most commercially available body fat analyzers. The working of analyzers includes passing an electrical current that follows the path of least resistance through the body. As fat contains less water, the fat-free mass has less resistance to electrical current. However, a large amount of fat underneath the skin is not detected by these analyzers. In addition, body impedance varies among different ethnic groups and influences the accuracy of body composition analyzers.

The multi-frequency bioimpedance analyzers segment is expected to grow at the highest CAGR during the forecast period

Based on the product, the bioimpedance analyzers market is segmented into multi-frequency bioimpedance analyzers, single-frequency bioimpedance analyzers, and dual-frequency bioimpedance analyzers. The consumables segment is projected to witness the highest growth during the forecast period. The preference for multi-frequency bioimpedance analyzers is high among end users as they can be used for both segmental and whole-body measurement, unlike single-frequency bioimpedance analyzers.

The application segment accounted for the largest share of the bioimpedance analyzers market in 2020

By application, the bioimpedance analyzers market is a segmented segmental body measurement and whole body measurement. The segmental body measurement segment accounted for the largest market share in 2020. The large share of this segment can be attributed to the increasing prevalence of obesity and metabolic disorders.

Fitness club and wellness centers for the largest share of the bioimpedance analyzers market in 2020

Based on end-users, the bioimpedance analyzers market is segmented into hospitals, fitness clubs and wellness centers, home users, and other end users The fitness clubs and wellness centers segment accounted for the largest share of the bioimpedance analyzers market in 2020. The increasing number of fitness clubs and wellness centers and the growing awareness about health and fitness across the globe are the major driving factor for this market.

North America accounted for the largest share of the bioimpedance analyzers market in 2020

Based on the region, the bioimpedance analyzers market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2020, North America accounted for the largest share of the bioimpedance analyzers market. The large share of North America can be attributed to factors such as the growing obesity rate, government initiatives to encourage healthy lifestyles, increasing use of body composition analyzers for assessing athlete fitness, and increasing number of health clubs and fitness centers.

Bioimpedance Analyzers Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Some of the major players operating in this market are Tanita Corporation (Japan), Omron Corporation (Japan). In 2020, Tanita Corporation (Japan) held the leading position in the market. The company has a strong geographic presence across North America, Europe, and Asia Pacific. Omron Corporation (Japan) held the second position in the bioimpedance analyzers market in 2020.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market Size Available for Years

2019–2026

Base Year Considered

2020

Forecast Period

2021–2026

Forecast Units

Value (USD Million)

Segments Covered

Products, Modality, Application, End User and Region

Geographies Covered

North America (US, Canada), Europe (Germany, France, UK, and RoE), APAC (China, India, Japan, and the RoAPAC), and Rest of the World

Companies Covered

Omron Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), seca GmbH & Co. KG (Germany), EVOLT 360 (Australia), SELVAS Healthcare (South Korea), Charder Electronic Co. Ltd. (China), Fook Tin Group Holding Ltd. (China), Bodystat Ltd. (UK), Maltron International (UK), Biotekna (Italy), Withings (France), Biodynamics Corporation (US), Akern (Italy), Xiaomi (China), Sino-Hero (Shenzhen) Bio-Medical Electronics Co., Ltd. (China), Lumsail Industrial Inc. (China), Guangzhou Beautylife Electronic Technology Co., Ltd. (China), and Bioparhom (France)

This research report categorizes the bioimpedance analyzers market into the following segments and subsegments:

Product

  • Multi-frequency Analyzers
  • Single-frequency Analyzers
  • Dual-frequency Analyzers

Modality

  • Wired Bioimpedance Analyzers
  • Wireless Bioimpedance Analyzers

Application

  • Whole-body Measurement
  • Segmental Body Measurement

End User

  • Fitness Clubs and Wellness Centers
  • Home Users
  • Hospitals
  • Other End User

Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • RoE 3
  • Asia Pacific
    • China
    • Japan
    • Taiwan
    • Australia
    • RoAPAC
  • Rest of the World

Recent Developments:

  • In 2020, Inbody launched the ThInBody 970 at CES Las Vegas
  • In 2017, Selvas Healthcare launched the ACCUNIQ BC380 artificial intelligence-based body composition analyzer globally.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 30)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 33)
    2.1 RESEARCH DATA
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
          FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
          FIGURE 5 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
          FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 COVID-19 SPECIFIC ASSUMPTIONS
    2.7 RISK ASSESSMENT/FACTOR ANALYSIS
          TABLE 1 RISK ASSESSMENT/FACTOR ANALYSIS
    2.8 COVID-19 HEALTH ASSESSMENT
    2.9 COVID-19 ECONOMIC ASSESSMENT
    2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO

3 EXECUTIVE SUMMARY (Page No. - 47)
    FIGURE 9 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    FIGURE 10 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021 VS. 2026 (USD MILLION)
    FIGURE 11 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021 VS. 2026 (USD MILLION)
    FIGURE 12 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    FIGURE 13 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 14 BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 52)
    4.1 BIOIMPEDANCE ANALYZERS MARKET OVERVIEW
          FIGURE 15 INCREASING INCIDENCE OF LIFESTYLE DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
    4.2 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION
          FIGURE 16 WHOLE-BODY MEASUREMENT SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
    4.3 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT AND COUNTRY, 2020
          FIGURE 17 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS DOMINATED THE NORTH AMERICAN MARKET IN 2020
    4.4 GEOGRAPHICAL SNAPSHOT OF THE BIOIMPEDANCE ANALYZERS MARKET
          FIGURE 18 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 55)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 19 BIOIMPEDANCE ANALYZERS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing prevalence of lifestyle diseases
                    5.2.1.2 Initiatives by governments and private organizations to promote healthy lifestyles
                    5.2.1.3 Growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers
           5.2.2 OPPORTUNITIES
                    5.2.2.1 Emerging markets across the Asia Pacific and Latin America
           5.2.3 CHALLENGES
                    5.2.3.1 Inconsistency in the accuracy of different bioimpedance analyzers
    5.3 COVID-19 IMPACT ANALYSIS
    5.4 RANGES/SCENARIOS
           5.4.1 BIOIMPEDANCE ANALYZERS MARKET
                    FIGURE 20 PESSIMISTIC SCENARIO
                    FIGURE 21 OPTIMISTIC SCENARIO
                    FIGURE 22 REALISTIC SCENARIO
    5.5 VALUE CHAIN ANALYSIS
          FIGURE 23 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES
    5.6 SUPPLY CHAIN ANALYSIS
          FIGURE 24 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
    5.7 PORTER’S FIVE FORCES ANALYSIS
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 INTENSITY OF COMPETITIVE RIVALRY
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 BARGAINING POWER OF SUPPLIERS
           5.7.5 THREAT OF SUBSTITUTES
    5.8 TECHNOLOGY ANALYSIS
    5.9 REGULATORY LANDSCAPE
          FIGURE 25 510(K) APPROVAL PROCESS
    5.10 PATENT ANALYSIS
    5.11 TRADE ANALYSIS
           5.11.1 TRADE ANALYSIS FOR BIOIMPEDANCE ANALYZERS
                     TABLE 2 IMPORT DATA FOR BIOIMPEDANCE ANALYZERS, BY COUNTRY, 2016–2020 (USD MILLION)
                     TABLE 3 EXPORT DATA FOR BIOIMPEDANCE ANALYZERS, BY COUNTRY, 2016–2020 (USD MILLION)
    5.12 PRICING ANALYSIS
           TABLE 4 PRICE RANGE FOR BIOIMPEDANCE ANALYZERS
    5.13 ECOSYSTEM ANALYSIS
           5.13.1 ROLE IN ECOSYSTEM
                     FIGURE 26 KEY PLAYERS IN THE BIOIMPEDANCE ANALYZERS ECOSYSTEM
    5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR BIOIMPEDANCE ANALYZER MANUFACTURERS
           5.14.2 REVENUE SHIFT FOR BIOIMPEDANCE ANALYZERS

6 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT (Page No. - 68)
    6.1 INTRODUCTION
          TABLE 5 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
          TABLE 6 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
    6.2 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS
           6.2.1 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS SEGMENT DOMINATED THE MARKET IN 2020
                    TABLE 7 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 8 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
    6.3 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS
           6.3.1 INCREASING OBESE POPULATION TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
                    TABLE 9 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 10 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
    6.4 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS
           6.4.1 INCREASING PREVALENCE OF CHRONIC DISORDERS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
                    TABLE 11 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 12 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)

7 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY (Page No. - 73)
    7.1 INTRODUCTION
          TABLE 13 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
          TABLE 14 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
    7.2 WIRELESS BIOIMPEDANCE ANALYZERS
           7.2.1 WIRELESS BIOIMPEDANCE ANALYZERS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
                    TABLE 15 WIRELESS BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 16 WIRELESS BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
    7.3 WIRED BIOIMPEDANCE ANALYZERS
           7.3.1 BENEFITS OF WIRED DEVICES TO DRIVE THEIR DEMAND AMONG END USERS
                    TABLE 17 WIRED BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 18 WIRED BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)

8 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE (Page No. - 77)
    8.1 INTRODUCTION
          TABLE 19 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2017–2019 (USD MILLION)
          TABLE 20 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2020–2026 (USD MILLION)
    8.2 CONSUMER-GRADE BIOIMPEDANCE ANALYZERS
           8.2.1 GROWING AWARENESS OF FITNESS AND TECHNOLOGICAL ADVANCEMENTS IN ANALYZERS TO DRIVE MARKET GROWTH
                    TABLE 21 CONSUMER-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 22 CONSUMER-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
    8.3 PROFESSIONAL-GRADE BIOIMPEDANCR ANALYZERS
           8.3.1 GROWING NUMBER OF FITNESS & WELLNESS CENTERS TO DRIVE MARKET GROWTH IN THE COMING YEARS
                    TABLE 23 PROFESSIONAL-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 24 PROFESSIONAL-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)

9 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION (Page No. - 81)
    9.1 INTRODUCTION
          TABLE 25 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
          TABLE 26 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
    9.2 SEGMENTAL BODY MEASUREMENT
           9.2.1 INCREASING INCIDENCE OF METABOLIC DISORDERS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
                    TABLE 27 BIOIMPEDANCE ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 28 BIOIMPEDANCE ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2020–2026 (USD MILLION)
    9.3 WHOLE-BODY MEASUREMENT
           9.3.1 WHOLE-BODY MEASUREMENT SEGMENT TO DOMINATE THE BIOIMPEDANCE ANALYZERS MARKET DURING THE FORECAST PERIOD
                    TABLE 29 BIOIMPEDANCE ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 30 BIOIMPEDANCE ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT, BY REGION, 2020–2026 (USD MILLION)

10 BIOIMPEDANCE ANALYZERS MARKET, BY END USER (Page No. - 85)
     10.1 INTRODUCTION
             TABLE 31 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
             TABLE 32 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
     10.2 HOME USERS
             10.2.1 HOME USERS SEGMENT TO DOMINATE THE BIOIMPEDANCE ANALYZERS MARKET
                       TABLE 33 BIOIMPEDANCE ANALYZERS MARKET FOR HOME USERS, BY REGION, 2017–2019 (USD MILLION)
                       TABLE 34 BIOIMPEDANCE ANALYZERS MARKET FOR HOME USERS, BY REGION, 2020–2026 (USD MILLION)
     10.3 FITNESS CLUBS AND WELLNESS CENTERS
             10.3.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
                       FIGURE 27 US: NUMBER OF HEALTH CLUBS, 2012–2019
                       TABLE 35 BIOIMPEDANCE ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY REGION, 2017–2019 (USD MILLION)
                       TABLE 36 BIOIMPEDANCE ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY REGION, 2020–2026 (USD MILLION)
     10.4 HOSPITALS
             10.4.1 INCREASING AWARENESS OF HEALTH AND FITNESS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
                       TABLE 37 BIOIMPEDANCE ANALYZERS MARKET FOR HOSPITALS, BY REGION, 2017–2019 (USD MILLION)
                       TABLE 38 BIOIMPEDANCE ANALYZERS MARKET FOR HOSPITALS, BY REGION, 2020–2026 (USD MILLION)
     10.5 OTHER END USERS
             TABLE 39 BIOIMPEDANCE ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2017–2019 (USD MILLION)
             TABLE 40 BIOIMPEDANCE ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2020–2026 (USD MILLION)

11 BIOIMPEDANCE ANALYZERS MARKET, BY REGION (Page No. - 92)
     11.1 INTRODUCTION
             TABLE 41 BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
             TABLE 42 BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
     11.2 NORTH AMERICA
             FIGURE 28 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
             TABLE 43 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
             TABLE 44 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
             TABLE 45 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
             TABLE 46 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
             TABLE 47 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
             TABLE 48 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
             TABLE 49 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2017–2019 (USD MILLION)
             TABLE 50 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2020–2026 (USD MILLION)
             TABLE 51 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
             TABLE 52 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
             TABLE 53 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
             TABLE 54 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             11.2.1 US
                        11.2.1.1 Increasing number of health clubs and fitness centers driving market growth in the US
                                      TABLE 55 US: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                      TABLE 56 US: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                      TABLE 57 US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                      TABLE 58 US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                      TABLE 59 US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                      TABLE 60 US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                      TABLE 61 US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                      TABLE 62 US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             11.2.2 CANADA
                        11.2.2.1 High prevalence of obesity in Canada to support market growth
                                      TABLE 63 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                      TABLE 64 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                      TABLE 65 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                      TABLE 66 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                      TABLE 67 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                      TABLE 68 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                      TABLE 69 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                      TABLE 70 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
     11.3 EUROPE
             TABLE 71 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
             TABLE 72 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
             TABLE 73 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
             TABLE 74 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
             TABLE 75 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2017–2019 (USD MILLION)
             TABLE 76 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2020–2026 (USD MILLION)
             TABLE 77 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
             TABLE 78 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
             TABLE 79 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
             TABLE 80 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
             TABLE 81 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
             TABLE 82 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             11.3.1 GERMANY
                        11.3.1.1 Germany is the largest market for bioimpedance analyzers in Europe
                                      TABLE 83 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                      TABLE 84 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                      TABLE 85 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                      TABLE 86 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                      TABLE 87 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                      TABLE 88 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                      TABLE 89 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                      TABLE 90 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             11.3.2 UK
                        11.3.2.1 UK is the second-largest market for bioimpedance analyzers in Europe
                                      TABLE 91 UK: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                      TABLE 92 UK: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                      TABLE 93 UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                      TABLE 94 UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                      TABLE 95 UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                      TABLE 96 UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                      TABLE 97 UK: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                      TABLE 98 UK: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Increasing obese population and rising prevalence of metabolic disorders to drive market growth in France
                                      TABLE 99 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                      TABLE 100 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                      TABLE 101 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                      TABLE 102 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                      TABLE 103 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                      TABLE 104 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                      TABLE 105 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                      TABLE 106 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             11.3.4 REST OF EUROPE
                       TABLE 107 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                       TABLE 108 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                       TABLE 109 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                       TABLE 110 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                       TABLE 111 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                       TABLE 112 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                       TABLE 113 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                       TABLE 114 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
     11.4 ASIA PACIFIC
             FIGURE 29 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
             TABLE 115 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
             TABLE 116 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
             TABLE 117 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
             TABLE 118 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
             TABLE 119 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, PRODUCT TYPE, 2017–2019 (USD MILLION)
             TABLE 120 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT TYPE, 2020–2026 (USD MILLION)
             TABLE 121 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
             TABLE 122 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
             TABLE 123 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
             TABLE 124 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
             TABLE 125 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
             TABLE 126 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             11.4.1 JAPAN
                        11.4.1.1 Strong presence of local players to drive market growth in Japan
                                      TABLE 127 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                      TABLE 128 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                      TABLE 129 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                      TABLE 130 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                      TABLE 131 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                      TABLE 132 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                      TABLE 133 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                      TABLE 134 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             11.4.2 CHINA
                        11.4.2.1 Increasing obese population to drive market growth in China
                                      TABLE 135 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                      TABLE 136 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                      TABLE 137 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                      TABLE 138 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                      TABLE 139 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                      TABLE 140 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                      TABLE 141 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                      TABLE 142 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             11.4.3 PHILIPPINES
                       TABLE 143 OBESITY PREVALENCE IN THE PHILIPPINES, 2010 VS. 2025
                       FIGURE 30 INCIDENCE OF DIABETES IN THE PHILIPPINES, 2010–2045
                       TABLE 144 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                       TABLE 145 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                       TABLE 146 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                       TABLE 147 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                       TABLE 148 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                       TABLE 149 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                       TABLE 150 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                       TABLE 151 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             11.4.4 TAIWAN
                        11.4.4.1 Increasing incidence of lifestyle diseases to drive market growth in Taiwan
                                      TABLE 152 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                      TABLE 153 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                      TABLE 154 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                      TABLE 155 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                      TABLE 156 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                      TABLE 157 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                      TABLE 158 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                      TABLE 159 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             11.4.5 AUSTRALIA
                        11.4.5.1 Increasing obese population to drive market growth in Australia
                                      TABLE 160 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                      TABLE 161 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                      TABLE 162 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                      TABLE 163 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                      TABLE 164 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                      TABLE 165 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                      TABLE 166 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                      TABLE 167 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             11.4.6 REST OF ASIA PACIFIC
                       TABLE 168 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                       TABLE 169 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                       TABLE 170 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                       TABLE 171 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                       TABLE 172 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                       TABLE 173 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                       TABLE 174 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                       TABLE 175 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
     11.5 REST OF THE WORLD
             TABLE 176 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
             TABLE 177 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
             TABLE 178 ROW: BIOIMPEDANCE ANALYZERS MARKET, PRODUCT TYPE, 2017–2019 (USD MILLION)
             TABLE 179 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT TYPE, 2020–2026 (USD MILLION)
             TABLE 180 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
             TABLE 181 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
             TABLE 182 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
             TABLE 183 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
             TABLE 184 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
             TABLE 185 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 150)
     12.1 OVERVIEW
     12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             TABLE 186 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE BIOIMPEDANCE ANALYZERS MARKET
     12.3 MARKET SHARE ANALYSIS
             TABLE 187 BIOIMPEDANCE ANALYZERS MARKET: DEGREE OF COMPETITION
             TABLE 188 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
             TABLE 189 EUROPE: BIOIMPEDANCE ANALYZERS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
             TABLE 190 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
     12.4 MARKET RANKING ANALYSIS
             TABLE 191 JAPAN: TOP COMPANIES IN THE BIOIMPEDANCE ANALYZERS MARKET, 2020
             TABLE 192 TAIWAN: TOP COMPANIES IN THE BIOIMPEDANCE ANALYZERS MARKET, 2020
             TABLE 193 PHILIPPINE: TOP COMPANIES IN THE BIOIMPEDANCE ANALYZERS MARKET, 2020
             TABLE 194 AUSTRALIA: TOP COMPANIES IN THE BIOIMPEDANCE ANALYZERS MARKET, 2020
     12.5 COMPANY EVALUATION MATRIX
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                        FIGURE 31 COMPANY EVALUATION MATRIX: BIOIMPEDANCE ANALYZERS MARKET
     12.6 COMPANY EVALUATION MATRIX (SMES/START-UPS)
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 STARTING BLOCKS
             12.6.3 RESPONSIVE COMPANIES
             12.6.4 DYNAMIC COMPANIES
                        FIGURE 32 COMPANY EVALUATION MATRIX: BIOIMPEDANCE ANALYZERS MARKET (SMES & START-UPS)
     12.7 COMPANY FOOTPRINT ANALYSIS
             TABLE 195 OVERALL FOOTPRINT OF COMPANIES IN THE BIOIMPEDANCE ANALYZERS MARKET
             TABLE 196 PRODUCT FOOTPRINT OF COMPANIES
             TABLE 197 REGIONAL FOOTPRINT OF COMPANIES

13 COMPANY PROFILES (Page No. - 161)
     13.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View)*
             13.1.1 OMRON CORPORATION
                        TABLE 198 OMRON CORPORATION: BUSINESS OVERVIEW
                        FIGURE 33 OMRON CORPORATION: COMPANY SNAPSHOT (2020)
             13.1.2 TANITA CORPORATION
                        TABLE 199 TANITA CORPORATION: BUSINESS OVERVIEW
             13.1.3 INBODY CO., LTD.
                        TABLE 200 INBODY CO., LTD.: BUSINESS OVERVIEW
             13.1.4 RJL SYSTEMS, INC.
                        TABLE 201 RJL SYSTEMS, INC.: BUSINESS OVERVIEW
             13.1.5 SECA GMBH & CO. KG
                        TABLE 202 SECA GMBH & CO. KG: BUSINESS OVERVIEW
             13.1.6 EVOLT 360
                        TABLE 203 EVOLT 360: BUSINESS OVERVIEW
             13.1.7 SELVAS HEALTHCARE (FORMERLY KNOWN AS JAWON MEDICAL)
                        TABLE 204 SELVAS HEALTHCARE: BUSINESS OVERVIEW
             13.1.8 FOOK TIN GROUP HOLDINGS LTD.
                        TABLE 205 FOOK TIN GROUP HOLDINGS LTD.: BUSINESS OVERVIEW
             13.1.9 BODYSTAT LTD.
                        TABLE 206 BODYSTAT LTD.: BUSINESS OVERVIEW
             13.1.10 CHARDER ELECTRONIC CO., LTD.
                        TABLE 207 CHARDER ELECTRONIC CO., LTD.: BUSINESS OVERVIEW
             13.1.11 MALTRON INTERNATIONAL
                        TABLE 208 MALTRON INTERNATIONAL: BUSINESS OVERVIEW
     13.2 START-UPS/SME PLAYERS
             13.2.1 BIOTEKNA
                        TABLE 209 BIOTEKNA: COMPANY OVERVIEW
             13.2.2 BIODYNAMICS CORPORATION
                        TABLE 210 BIODYNAMICS CORPORATION: COMPANY OVERVIEW
             13.2.3 AKERN
                        TABLE 211 AKERN: COMPANY OVERVIEW
             13.2.4 WITHINGS
                        TABLE 212 WITHINGS: COMPANY OVERVIEW
             13.2.5 XIAOMI
                        TABLE 213 XIAOMI: COMPANY OVERVIEW
             13.2.6 SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD.
                        TABLE 214 SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
             13.2.7 LUMSAIL INDUSTRIAL INC.
                        TABLE 215 LUMSAIL INDUSTRIAL INC.: COMPANY OVERVIEW
             13.2.8 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.
                        TABLE 216 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
             13.2.9 BIOPARHOM
                        TABLE 217 BIOPARHOM: COMPANY OVERVIEW
             13.2.10 MICROLIFE
                        TABLE 218 MICROLIFE: COMPANY OVERVIEW
     13.3 INDICATIVE LIST OF BIOIMPEDANCE ANALYZER MANUFACTURERS:

* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 186)
     14.1 DISCUSSION GUIDE
     14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     14.3 AVAILABLE CUSTOMIZATIONS
     14.4 RELATED REPORTS
     14.5 AUTHOR DETAILS

The study involved four major activities in estimating the current size of the bioimpedance analyzers market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (hospitals, fitness laboratories and wellness centers, home users) and supply sides (bioimpedance analyzer manufacturers and distributors).

The following is a breakdown of the primary respondents:

Bioimpedance Analyzers Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the bioimpedance analyzers market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the bioimpedance analyzers industry.

Report Objectives

  • To define, describe, and forecast the global bioimpedance analyzers market based on product, modality, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, new product launches, and partnerships in the bioimpedance analyzers market

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
  • Geographic Analysis: Further breakdown of Rest of the World bioimpedance analyzers market into specific countries bioimpedance analyzers market and further breakdown of the European bioimpedance analyzers market into specific countries
Report Code
MD 7973
Published ON
Sep, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Bioimpedance Analyzers Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback